Infographic: 5 Key Biosimilars Terms Defined

At the AAM Biosimilar Council Conference 2017, Hillel Cohen, executive director of scientific affairs at Sandoz, disambiguated key terms in biosimilars.

Related Content:

AAM Biosimilars Council ConferenceConference

Follow-On Biologics Poised to Expand Global Health Care Access and Lower Costs

Yesintek Biosimilar Shows Comparable Efficacy, Lower Immunogenicity Than Stelara, Says Elena Wolff-Holz, MD

Oncology Biosimilars Cut Costs; Diabetes and Other Diseases Could Follow